Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 1—January 2004

Estimating the Public Health Impact of Rabies

Paul G. Coleman*Comments to Author , Eric M. Fèvre†, and Sarah Cleaveland†
Author affiliations: *London School of Hygiene and Tropical Medicine, London, England; †Centre for Tropical Veterinary Medicine, University of Edinburgh, Edinburgh, Scotland

Main Article

Table 2

The global DALY scores for rabies and other selected diseasesa,b

Disease Total DALYs lost (x 1,000)
Malaria 42,280
Tuberculosis 36,040
Lymphatic filariasis 5,644
Leishmaniasis 2,357
Schistosomiasis 1,760
Trypanosomiasis 1,598
RABIES 1,160
Onchocerciasis 987
Chagas 649
Dengue 653
Leprosy 177

aDALY, disability-adjusted life year.
bThe DALY score for rabies was based on official World Health Organization (WHO) figures (10). The other listed diseases constitute the official DALY score in 2001 for the priority diseases in the TDR (United Nations Development Program/World Bank/WHO Special Programme for Research and Training in Tropical Diseases) portfolio (8).

Main Article

  1. Rupprecht  CE, Hanlon  CA, Hemachudha  T. Rabies re-examined. Lancet Infect Dis. 2002;2:32743. DOIPubMedGoogle Scholar
  2. Taylor  LH, Latham  SM, Woolhouse  MEJ. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci. 2001;356:9839. DOIPubMedGoogle Scholar
  3. World Health Organization. Strategies for the control and elimination of rabies in Asia. Report of a WHO interregional consultation. Geneva: The Organization; 2002.
  4. Rutebarika  C, Winyi-Kaboyo  R, Barrat  J, King  A, eds. Proceedings of the Southern and Eastern African Rabies Group meeting. Entebbe, Uganda: Fondation Marcel Merieux; 2000.
  5. Bögel  K, Meslin  F-X. Economics of human and canine rabies elimination: guidelines for programme orientation. Bull World Health Organ. 1990;68:28191.PubMedGoogle Scholar
  6. Murray  CJL, Lopez  AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press; 1996.
  7. World Health Organization. Investing in health research and development: report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options. Geneva: The Organization; 1996.
  8. World Health Organization. The world health report 2002: reducing risks, promoting healthy life. Geneva: The Organization, 2002.
  9. Cleaveland  S, Fèvre  EM, Kaare  M, Coleman  PG. Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries. Bull World Health Organ. 2002;80:30410.PubMedGoogle Scholar
  10. World Health Organization. World survey of rabies no. 32 for the Year 1996. Geneva: The Organization; 1998.
  11. Remme  JHF, Blas  E, Chitsulo  L, Desjeux  MP, Engers  HD, Kanyok  TP, Strategic emphases on tropical diseases research: a TDR perspective. Trends Parasitol. 2002;18:4216. DOIPubMedGoogle Scholar
  12. Eng  TR, Fishbein  DB, Talamante  HE, Hall  DB, Chavez  GF, Dobbins  JG, Urban epizootic of rabies in Mexico—epidemiology and impact of animal bite injuries. Bull World Health Organ. 1993;71:61524.PubMedGoogle Scholar
  13. World Health Organization. World survey of rabies no. 27 for the Year 1991. Geneva: The Organization; 1993.
  14. Kitala  PM, McDermott  JJ, Kyule  MN, Gathuma  JM. Community-based active surveillance for rabies in Machakos District, Kenya. Prev Vet Med. 2000;44:7385. DOIPubMedGoogle Scholar
  15. Pan American Health Organization. Human rabies in the Americas. Epidemiol Bull. 1995;16:123.PubMedGoogle Scholar

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.